Spencer R. Berthelsen - 15 Jul 2021 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role: Director
Signature: By: Patrick R. O'Neil, attorney-in-fact For: Spencer R. Berthelsen
Issuer symbol: IONS
Transactions as of: 15 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 19 Jul 2021, 20:13:10 UTC
Previous filing: 06 Jul 2021
Next filing: 09 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IONS	Common Stock	Options Exercise	$0	+5,333	+5.3%	$0.000000	106,316	15 Jul 2021	Direct	F1
transaction	IONS	Common Stock	Options Exercise	$0	+889	+0.84%	$0.000000	107,205	15 Jul 2021	Direct	F1
transaction	IONS	Common Stock	Options Exercise	$0	+666	+0.62%	$0.000000	107,871	15 Jul 2021	Direct	F1
transaction	IONS	Common Stock	Options Exercise	$0	+1,778	+1.6%	$0.000000	109,649	15 Jul 2021	Direct	F1
holding	IONS	Common Stock						70	15 Jul 2021	by Daughter	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IONS	Restricted Stock Unit	Options Exercise	$0	-5,333	-29%	$0.000000	13,108	15 Jul 2021	Common Stock	5,333	$0.000000	Direct	F3, F4
transaction	IONS	Restricted Stock Unit	Options Exercise	$0	-889	-6.8%	$0.000000	12,219	15 Jul 2021	Common Stock	889	$0.000000	Direct	F3, F5
transaction	IONS	Restricted Stock Unit	Options Exercise	$0	-666	-5.5%	$0.000000	11,553	15 Jul 2021	Common Stock	666	$0.000000	Direct	F3, F5
transaction	IONS	Restricted Stock Unit	Options Exercise	$0	-1,778	-15%	$0.000000	9,775	15 Jul 2021	Common Stock	1,778	$0.000000	Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award.
F2	The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3	Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F4	Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
F5	Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.